| Public Shareholders 69 companies · $11508.4B | 69 companies | $11508.4B | Oncology |
| F-Prime Capital 16 companies · $651.5B | 16 companies | $651.5B | Oncology |
| Eight Roads Ventures 3 companies · $651.5B | 3 companies | $651.5B | Metabolic |
| Thermo Fisher Scientific 3 companies · $542.4B | 3 companies | $542.4B | Oncology |
| GIC 3 companies · $177.3B | 3 companies | $177.3B | Oncology |
| Hillhouse Capital 55 companies · $158.0B | 55 companies | $158.0B | Oncology |
| Boyu Capital 14 companies · $158.0B | 14 companies | $158.0B | Oncology |
| Eli Lilly 2 companies · $158.0B | 2 companies | $158.0B | Rare Diseases |
| Stryker Corporation 2 companies · $127.0B | 2 companies | $127.0B | Chronic Back Pain |
| Public market investors 11 companies · $40.9B | 11 companies | $40.9B | Immunology |
| Teva Pharmaceutical Industries Ltd. 2 companies · $35.0B | 2 companies | $35.0B | Pain Management |
| Third Rock Ventures 12 companies · $32.6B | 12 companies | $32.6B | Oncology |
| The Column Group 14 companies · $31.0B | 14 companies | $31.0B | Oncology |
| Flagship Pioneering 30 companies · $20.1B | 30 companies | $20.1B | Oncology |
| Abbott 2 companies · $20.0B | 2 companies | $20.0B | Women's Health |
| TPG 3 companies · $17.0B | 3 companies | $17.0B | Respiratory |
| Hologic, Inc. 2 companies · $16.9B | 2 companies | $16.9B | Oncology |
| ARCH Venture Partners 50 companies · $15.6B | 50 companies | $15.6B | Oncology |
| Polaris Partners 15 companies · $12.3B | 15 companies | $12.3B | Oncology |
| EcoR1 Capital 7 companies · $11.3B | 7 companies | $11.3B | Oncology |
| Timothy Springer 2 companies · $11.3B | 2 companies | $11.3B | Neuromuscular |
| Sanofi 7 companies · $10.8B | 7 companies | $10.8B | Oncology |
| Longitude Capital 5 companies · $10.6B | 5 companies | $10.6B | Obesity |
| Donaldson Company, Inc. 2 companies · $10.1B | 2 companies | $10.1B | — |
| Forbion 24 companies · $7.6B | 24 companies | $7.6B | Oncology |
| Medicxi 8 companies · $6.1B | 8 companies | $6.1B | Oncology |
| General Atlantic 3 companies · $6.1B | 3 companies | $6.1B | Oncology |
| Decheng Capital 5 companies · $6.0B | 5 companies | $6.0B | Oncology |
| Ally Bridge Group 2 companies · $6.0B | 2 companies | $6.0B | Autoimmune Diseases |
| Redmile Group 7 companies · $5.8B | 7 companies | $5.8B | Oncology |
| Roivant Sciences 3 companies · $5.8B | 3 companies | $5.8B | Autoimmune Diseases |
| Public Shareholders (HKEX) 2 companies · $4.7B | 2 companies | $4.7B | Oncology |
| Bain Capital Life Sciences 5 companies · $3.7B | 5 companies | $3.7B | Respiratory |
| Surveyor Capital 4 companies · $3.6B | 4 companies | $3.6B | Immunology |
| Atlas Venture 39 companies · $3.4B | 39 companies | $3.4B | Oncology |
| Gilead Sciences Inc. 3 companies · $3.2B | 3 companies | $3.2B | Oncology |
| MPM Capital 8 companies · $3.0B | 8 companies | $3.0B | Oncology |
| Vida Ventures 5 companies · $3.0B | 5 companies | $3.0B | Oncology |
| Dexcel Pharma 2 companies · $3.0B | 2 companies | $3.0B | Oncology |
| Versant Ventures 18 companies · $2.0B | 18 companies | $2.0B | Oncology |
| NovaQuest Capital Management 2 companies · $2.0B | 2 companies | $2.0B | Women's Health |
| GSK plc 2 companies · $1.7B | 2 companies | $1.7B | HIV/AIDS |
| Pfizer Inc. 2 companies · $1.5B | 2 companies | $1.5B | HIV/AIDS |
| Pontifax 8 companies · $1.5B | 8 companies | $1.5B | Oncology |
| Sequoia Capital 4 companies · $1.3B | 4 companies | $1.3B | Oncology |
| BVF Partners 3 companies · $1.3B | 3 companies | $1.3B | Genetics & Genomics |
| RA Capital 6 companies · $1.1B | 6 companies | $1.1B | Oncology |
| Azenta Life Sciences 2 companies · $1.0B | 2 companies | $1.0B | Oncology |
| Eli Lilly and Company (Acquirer) 3 companies · $1.0B | 3 companies | $1.0B | Neurodegenerative Diseases |
| Perceptive Advisors (via Board representation) 2 companies · $986.5M | 2 companies | $986.5M | Oncology |
| Deep Track Capital 2 companies · $899.0M | 2 companies | $899.0M | Autoimmune Diseases |
| OPKO Health, Inc. 3 companies · $875.2M | 3 companies | $875.2M | Oncology |
| Revolution Growth 2 companies · $870.2M | 2 companies | $870.2M | Oncology |
| BridgeBio Pharma 2 companies · $656.9M | 2 companies | $656.9M | Rare Genetic Diseases |
| EQT Life Sciences 3 companies · $583.6M | 3 companies | $583.6M | Ophthalmology |
| Vertex Ventures HC 8 companies · $553.7M | 8 companies | $553.7M | Neuroscience |
| Pivotal Bioventure Partners 2 companies · $553.7M | 2 companies | $553.7M | Neuroscience |
| Cystic Fibrosis Foundation 6 companies · $535.9M | 6 companies | $535.9M | Infectious Disease |
| Samsara BioCapital 7 companies · $513.7M | 7 companies | $513.7M | Oncology |
| OrbiMed 41 companies · $513.2M | 41 companies | $513.2M | Oncology |
| Fidelity Management & Research Company 8 companies · $469.8M | 8 companies | $469.8M | Oncology |
| Syncona 7 companies · $441.8M | 7 companies | $441.8M | Oncology |
| Bristol Myers Squibb 7 companies · $416.6M | 7 companies | $416.6M | Oncology |
| Leaps by Bayer 4 companies · $416.6M | 4 companies | $416.6M | Oncology |
| Bayer AG 2 companies · $416.6M | 2 companies | $416.6M | Neuromuscular |
| Perceptive Advisors 6 companies · $397.2M | 6 companies | $397.2M | Oncology |
| Venrock 7 companies · $385.0M | 7 companies | $385.0M | Metabolic Disease |
| Mubadala Capital 6 companies · $369.0M | 6 companies | $369.0M | Immunology |
| Amgen 2 companies · $369.0M | 2 companies | $369.0M | Cardiovascular Disease |
| Truffle Capital 4 companies · $321.3M | 4 companies | $321.3M | Rheumatology |
| Dementia Discovery Fund 6 companies · $273.2M | 6 companies | $273.2M | Neurodegenerative Diseases |
| Google Ventures 5 companies · $273.2M | 5 companies | $273.2M | Oncology |
| Topspin Partners 2 companies · $273.2M | 2 companies | $273.2M | Neurodegenerative Diseases |
| New Enterprise Associates (NEA) 7 companies · $240M | 7 companies | $240M | Oncology |
| Fairmount 2 companies · $240M | 2 companies | $240M | Immunology |
| Novartis 2 companies · $202.5M | 2 companies | $202.5M | Oncology |
| Fortress Biotech 3 companies · $146.5M | 3 companies | $146.5M | Oncology |
| Bpifrance 14 companies · $132.4M | 14 companies | $132.4M | Oncology |
| Soleus Capital 2 companies · $131.9M | 2 companies | $131.9M | Oncology |
| Omega Funds 7 companies · $128.3M | 7 companies | $128.3M | Oncology |
| Frazier Life Sciences 6 companies · $128.3M | 6 companies | $128.3M | Immunology |
| RA Capital Management 19 companies · $71.5M | 19 companies | $71.5M | Oncology |
| Vivo Capital 5 companies · $71.5M | 5 companies | $71.5M | Oncology |
| Business Angels 2 companies · $66.9M | 2 companies | $66.9M | Oncology |
| Merck Global Health Innovation Fund 4 companies · $55.5M | 4 companies | $55.5M | Synthetic Biology |
| Cancer Prevention and Research Institute of Texas (CPRIT) 5 companies · $44.0M | 5 companies | $44.0M | Oncology |
| Oxford Science Enterprises (OSE) 2 companies · $28.6M | 2 companies | $28.6M | Rare Respiratory Diseases |
| RTW Investments 5 companies · $22.5M | 5 companies | $22.5M | Endocrinology |
| Founders 8 companies · $17.9M | 8 companies | $17.9M | Oncology |
| European Investment Bank (EIB) 7 companies · $12.2M | 7 companies | $12.2M | Cardiovascular |
| Northpond Ventures 7 companies · $98K | 7 companies | $98K | Cell & Gene Therapy |
| Claris Ventures 2 companies · $98K | 2 companies | $98K | Antibody Discovery |
| Not Publicly Disclosed 67 companies | 67 companies | — | Oncology |
| Information not widely publicized 63 companies | 63 companies | — | Oncology |
| Sequoia Capital China 45 companies | 45 companies | — | Oncology |
| National Institutes of Health (NIH) 42 companies | 42 companies | — | Oncology |
| Qiming Venture Partners 39 companies | 39 companies | — | Oncology |
| Lilly Asia Ventures 25 companies | 25 companies | — | Oncology |
| Private Investors 25 companies | 25 companies | — | Oncology |
| Public Markets 24 companies | 24 companies | — | Oncology |
| Khosla Ventures 20 companies | 20 companies | — | Oncology |
| GV 18 companies | 18 companies | — | Oncology |
| Angel investors 18 companies | 18 companies | — | Oncology |
| Sofinnova Partners 18 companies | 18 companies | — | Oncology |
| TF Capital 17 companies | 17 companies | — | Oncology |
| Novo Holdings 15 companies | 15 companies | — | Oncology |
| Temasek 14 companies | 14 companies | — | Oncology |
| Y Combinator 14 companies | 14 companies | — | Oncology |
| Andreessen Horowitz 13 companies | 13 companies | — | Oncology |
| GL Ventures 13 companies | 13 companies | — | Oncology |
| Novartis Venture Fund 12 companies | 12 companies | — | Oncology |
| OrbiMed Asia 12 companies | 12 companies | — | Oncology |
| Sinovation Ventures 12 companies | 12 companies | — | Oncology |
| Undisclosed 11 companies | 11 companies | — | Oncology |
| Deerfield Management 11 companies | 11 companies | — | Oncology |
| CBC Group 11 companies | 11 companies | — | Oncology |
| M Ventures 11 companies | 11 companies | — | Oncology |
| Cormorant Asset Management 10 companies | 10 companies | — | Oncology |
| SV Health Investors 10 companies | 10 companies | — | Oncology |
| Information not publicly available 9 companies | 9 companies | — | Oncology |
| Sanofi Ventures 9 companies | 9 companies | — | Immunology |
| Torrey Pines Investment 8 companies | 8 companies | — | Oncology |
| 5AM Ventures 8 companies | 8 companies | — | Oncology |
| LYFE Capital 8 companies | 8 companies | — | Oncology |
| Ysios Capital 8 companies | 8 companies | — | Neuroscience |
| Alexandria Venture Investments 8 companies | 8 companies | — | Immunology |
| Section 32 8 companies | 8 companies | — | Oncology |
| Janus Henderson Investors 8 companies | 8 companies | — | Oncology |
| Access Biotechnology 8 companies | 8 companies | — | Immunology |
| National Cancer Institute (NCI) 8 companies | 8 companies | — | Oncology |
| New Enterprise Associates 8 companies | 8 companies | — | Oncology |
| National Science Foundation (NSF) 8 companies | 8 companies | — | Oncology |
| Bill & Melinda Gates Foundation 8 companies | 8 companies | — | Oncology |
| Lightspeed Venture Partners 8 companies | 8 companies | — | Oncology |
| Uniseed 7 companies | 7 companies | — | Immunology |
| Founders Fund 7 companies | 7 companies | — | Neurology |
| Droia Ventures 7 companies | 7 companies | — | Oncology |
| Andera Partners 7 companies | 7 companies | — | Oncology |
| Shanghai Healthcare Capital 7 companies | 7 companies | — | Oncology |
| National Science Foundation (SBIR Grant) 7 companies | 7 companies | — | Oncology |
| Innovate UK 7 companies | 7 companies | — | Oncology |
| Strategic Corporate Investors 6 companies | 6 companies | — | Oncology |
| Undisclosed Venture Capital 6 companies | 6 companies | — | Oncology |
| Casdin Capital 6 companies | 6 companies | — | Oncology |
| DCVC 6 companies | 6 companies | — | Oncology |
| Sinopharm Capital 6 companies | 6 companies | — | Oncology |
| Arboretum Ventures 6 companies | 6 companies | — | Cardiology |
| Abingworth 6 companies | 6 companies | — | Oncology |
| Lux Capital 6 companies | 6 companies | — | Neuroscience |
| Illumina Ventures 6 companies | 6 companies | — | Oncology |
| ArchiMed 6 companies | 6 companies | — | Dental Implantology |
| Series A Investors (Undisclosed) 6 companies | 6 companies | — | Oncology |
| Venture Capital Firms 6 companies | 6 companies | — | Oncology |
| Invus 6 companies | 6 companies | — | Oncology |
| Longwood Fund 6 companies | 6 companies | — | Oncology |
| T. Rowe Price 6 companies | 6 companies | — | Oncology |
| Advent Life Sciences 6 companies | 6 companies | — | Oncology |
| European Innovation Council (EIC) Fund 6 companies | 6 companies | — | Oncology |
| LifeArc Ventures 5 companies | 5 companies | — | Oncology |
| Legend Capital 5 companies | 5 companies | — | Oncology |
| DCVC Bio 5 companies | 5 companies | — | Oncology |
| Brandon Capital 5 companies | 5 companies | — | Oncology |
| Shenzhen Capital Group 5 companies | 5 companies | — | Oncology |
| General Catalyst 5 companies | 5 companies | — | Cardiovascular Disease |
| Seventure Partners 5 companies | 5 companies | — | Metabolic Disease |
| Johnson & Johnson Innovation – JJDC 5 companies | 5 companies | — | Ophthalmology |
| Gimv 5 companies | 5 companies | — | Hematology |
| Sofinnova Investments 5 companies | 5 companies | — | Ophthalmology |
| Sequoia Capital India 5 companies | 5 companies | — | Cardiovascular |
| Pfizer Ventures 5 companies | 5 companies | — | Oncology |
| Unknown 5 companies | 5 companies | — | Oncology |
| Venture capital firms (specific names not widely publicized) 5 companies | 5 companies | — | Oncology |
| CCB International 5 companies | 5 companies | — | Oncology |
| 3H Health Investment 5 companies | 5 companies | — | Oncology |
| Monograph Capital 5 companies | 5 companies | — | Immunology |
| Canaan Partners 5 companies | 5 companies | — | Oncology |
| SR One 5 companies | 5 companies | — | Pulmonary Fibrosis |
| Playground Global 5 companies | 5 companies | — | Immunology |
| Shifamed 5 companies | 5 companies | — | Cardiovascular |
| Family offices 5 companies | 5 companies | — | Depression |
| Danaher Corporation 5 companies | 5 companies | — | Oncology |
| Foresite Capital 5 companies | 5 companies | — | Oncology |
| Johnson & Johnson Innovation 4 companies | 4 companies | — | Gastroenterology |
| Boxer Capital 4 companies | 4 companies | — | Oncology |
| Euclidean Capital 4 companies | 4 companies | — | Immunology |
| Lightstone Ventures 4 companies | 4 companies | — | Ophthalmology |
| HealthCap 4 companies | 4 companies | — | Rare Disease |
| 8VC 4 companies | 4 companies | — | Oncology |
| Hadean Ventures 4 companies | 4 companies | — | Oncology |
| Nextech Invest 4 companies | 4 companies | — | Oncology |
| Undisclosed seed investors 4 companies | 4 companies | — | Kidney disease |
| Venture capital firms (specific names not widely disclosed) 4 companies | 4 companies | — | Oncology |
| Baidu Ventures 4 companies | 4 companies | — | Oncology |
| 6 Dimensions Capital 4 companies | 4 companies | — | Oncology |
| European Innovation Council (EIC Accelerator) 4 companies | 4 companies | — | Oncology |
| BPI France 4 companies | 4 companies | — | Addiction |
| Innosuisse 4 companies | 4 companies | — | Metabolic Disorders |
| Loyal Valley Capital 4 companies | 4 companies | — | Diagnostics |
| Matrix Partners China 4 companies | 4 companies | — | Genetics & Genomics |
| Venture capital details not widely publicized 4 companies | 4 companies | — | Oncology |
| Information not publicly specified 4 companies | 4 companies | — | Oncology |
| Bruker Corporation 4 companies | 4 companies | — | Oncology |
| Private Angel Investors 4 companies | 4 companies | — | Oncology |
| Kurma Partners 4 companies | 4 companies | — | Alzheimer's Disease |
| National Science Foundation 4 companies | 4 companies | — | Oncology |
| Ampersand Capital Partners 4 companies | 4 companies | — | Rare Diseases |
| Connecticut Innovations 4 companies | 4 companies | — | Oncology |
| Series A Investors 4 companies | 4 companies | — | Musculoskeletal Diseases |
| Series B Investors 4 companies | 4 companies | — | Musculoskeletal Diseases |
| NIH 4 companies | 4 companies | — | Oncology |
| National Institute of Allergy and Infectious Diseases (NIAID) 4 companies | 4 companies | — | Infectious Disease |
| Mission BioCapital 4 companies | 4 companies | — | Oncology |
| Pillar VC 4 companies | 4 companies | — | Endometriosis |
| UCB Ventures 4 companies | 4 companies | — | Neurology |
| Delos Capital 4 companies | 4 companies | — | Cardiovascular Disease |
| Adbio Partners 4 companies | 4 companies | — | Autoimmune Diseases |
| Astellas Venture Management 4 companies | 4 companies | — | Oncology |
| Flerie Invest 4 companies | 4 companies | — | Obesity |
| U.S. Department of Defense 4 companies | 4 companies | — | Hematology |
| BioGeneration Ventures (BGV) 4 companies | 4 companies | — | Oncology |
| Venture Capital (unspecified) 4 companies | 4 companies | — | Rare Diseases |
| Santé Ventures 4 companies | 4 companies | — | Neurovascular |
| Gilde Healthcare 4 companies | 4 companies | — | Neurovascular |
| Noshaq 4 companies | 4 companies | — | Oncology |
| IP Group 4 companies | 4 companies | — | Oncology |
| SoftBank Vision Fund 4 companies | 4 companies | — | — |
| Information not widely published 4 companies | 4 companies | — | Oncology |
| Bessemer Venture Partners 4 companies | 4 companies | — | Oncology |
| Israel Innovation Authority 4 companies | 4 companies | — | Prenatal genetics |
| Main Sequence Ventures 3 companies | 3 companies | — | Immunology |
| Teal Ventures 3 companies | 3 companies | — | Oncology |
| Octopus Ventures 3 companies | 3 companies | — | Oncology |
| LocalGlobe 3 companies | 3 companies | — | Oncology |
| Cambridge Innovation Capital 3 companies | 3 companies | — | Oncology |
| BioGeneration Ventures 3 companies | 3 companies | — | Hematology |
| PMV 3 companies | 3 companies | — | Infectious Disease |
| Sectoral Asset Management 3 companies | 3 companies | — | Immunology |
| Morningside Ventures 3 companies | 3 companies | — | Metabolic Disorders |
| Roche 3 companies | 3 companies | — | Rare Diseases |
| EQT 3 companies | 3 companies | — | Cardiovascular |
| IDG Ventures 3 companies | 3 companies | — | Oncology |
| Sherpa Healthcare Partners 3 companies | 3 companies | — | Oncology |
| CITIC Private Equity 3 companies | 3 companies | — | Cardiovascular |
| Thuja Capital 3 companies | 3 companies | — | Hematology |
| Broadview Ventures 3 companies | 3 companies | — | Cardiology |
| Private investors (undisclosed) 3 companies | 3 companies | — | Proteomics |
| Georgia Research Alliance 3 companies | 3 companies | — | Neurology & Psychiatry |
| aMoon 3 companies | 3 companies | — | Ophthalmology |
| Sound Bioventures 3 companies | 3 companies | — | Genetic Disorders |
| Venture Kick 3 companies | 3 companies | — | Infectious Disease |
| Research Council of Norway 3 companies | 3 companies | — | Ophthalmology |
| Two Sigma Ventures 3 companies | 3 companies | — | Neuroscience |
| Dolby Family Ventures 3 companies | 3 companies | — | Alzheimer's Disease |
| Norwest Venture Partners 3 companies | 3 companies | — | Pulmonary Fibrosis |
| National Cancer Institute (SBIR Grant) 3 companies | 3 companies | — | Oncology |
| Anzu Partners 3 companies | 3 companies | — | Oncology |
| National Institutes of Health (SBIR Grant) 3 companies | 3 companies | — | Postoperative Pain |
| Aditum Bio 3 companies | 3 companies | — | Substance Use Disorders |
| Alphabet Inc. 3 companies | 3 companies | — | Aging |
| Private Equity 3 companies | 3 companies | — | Infectious Disease |
| Shangbay Capital 3 companies | 3 companies | — | Cardiovascular |
| Insight Partners 3 companies | 3 companies | — | Oncology |
| National Institutes of Health 3 companies | 3 companies | — | Orthopedics |
| DARPA 3 companies | 3 companies | — | Orthopedics |
| ARTIS Ventures 3 companies | 3 companies | — | Cardiovascular Disease |
| Prime Movers Lab 3 companies | 3 companies | — | Regenerative Medicine |
| Johnson & Johnson 3 companies | 3 companies | — | Neuropsychiatric |
| AbbVie Ventures 3 companies | 3 companies | — | Ophthalmology |
| 2Invest 3 companies | 3 companies | — | Oncology |
| Merck KGaA, Darmstadt, Germany 3 companies | 3 companies | — | Oncology |
| HOYA Corporation 3 companies | 3 companies | — | Minimally Invasive Surgery |
| Newpath Partners 3 companies | 3 companies | — | Oncology |
| BioAdvance 3 companies | 3 companies | — | Mitochondrial Disease |
| Jeito Capital 3 companies | 3 companies | — | Neurology |
| Undisclosed Pre-seed Investors 3 companies | 3 companies | — | Oncology |
| North Carolina Biotechnology Center 3 companies | 3 companies | — | Urology |
| Red Tree Venture Capital 3 companies | 3 companies | — | Oncology |
| CPE 3 companies | 3 companies | — | Oncology |
| VIB 3 companies | 3 companies | — | Inflammatory Bowel Diseases |
| Takeda 3 companies | 3 companies | — | Oncology |
| National Institute on Drug Abuse (NIDA) 3 companies | 3 companies | — | Opioid Use Disorder |
| Wellington Partners 3 companies | 3 companies | — | Sepsis |
| National Institutes of Health (SBIR Grants) 3 companies | 3 companies | — | Alzheimer's Disease |
| High-Tech Gründerfonds 3 companies | 3 companies | — | Infectious Disease |
| venBio Partners 3 companies | 3 companies | — | Neurology |
| Alta Partners 3 companies | 3 companies | — | Rare Diseases |
| Series B Investors (Undisclosed) 3 companies | 3 companies | — | Cardiovascular |
| NIH SBIR 3 companies | 3 companies | — | Orthopedics |
| BioMedPartners 3 companies | 3 companies | — | Infectious Disease |
| ENISA 3 companies | 3 companies | — | Neurology |
| Roche Venture Fund 3 companies | 3 companies | — | Ophthalmology |
| European Union Horizon 2020 3 companies | 3 companies | — | Cardiovascular |
| Westlake Village BioPartners 3 companies | 3 companies | — | Oncology |
| Epidarex Capital 3 companies | 3 companies | — | Cystic Fibrosis |
| Boehringer Ingelheim Venture Fund 3 companies | 3 companies | — | Neurodegenerative Diseases |
| Sunstone Life Science Ventures 3 companies | 3 companies | — | Psychiatry |
| CICC 3 companies | 3 companies | — | Gastrointestinal Diseases |
| BlackRock 3 companies | 3 companies | — | Oncology |
| Government Grants 3 companies | 3 companies | — | Infectious Disease |
| IQ Capital 3 companies | 3 companies | — | Oncology |
| LifeSci Venture Partners 3 companies | 3 companies | — | Oncology |
| GV (Google Ventures) 3 companies | 3 companies | — | Oncology |
| UTokyo Innovation Platform Co., Ltd. 3 companies | 3 companies | — | Oncology |
| Venture capital/Private equity (specific names not widely published) 3 companies | 3 companies | — | Infectious Disease |
| Venture Capital/Private Equity (specific names not widely publicized) 3 companies | 3 companies | — | Reproductive Health |
| Pitango Venture Capital 3 companies | 3 companies | — | Chronic Neuropathic Pain |
| OurCrowd 3 companies | 3 companies | — | Chronic Neuropathic Pain |
| Kyoto University Innovation Capital Co., Ltd. 3 companies | 3 companies | — | Regenerative Medicine |
| Cathay Innovation 2 companies | 2 companies | — | Oncology |
| Seed investors (undisclosed) 2 companies | 2 companies | — | Oncology |
| Meltwind 2 companies | 2 companies | — | Oncology |
| Seedcamp 2 companies | 2 companies | — | Oncology |
| Macquarie Group 2 companies | 2 companies | — | Acute Pain |
| Mithril Capital 2 companies | 2 companies | — | Dry Eye Disease |
| Medical Research Commercialisation Fund 2 companies | 2 companies | — | Oncology |
| Mitsui & Co. 2 companies | 2 companies | — | Oncology |
| Mayo Clinic 2 companies | 2 companies | — | Cardiovascular Disease |
| Corporate Pharma Partner 2 companies | 2 companies | — | AI / Machine Learning |
| Alira Health 2 companies | 2 companies | — | Cardiovascular |
| Brandon Capital Partners 2 companies | 2 companies | — | Oncology |
| Presight Capital 2 companies | 2 companies | — | Regenerative Medicine |
| HongShan 2 companies | 2 companies | — | Surgery |
| Temasek Holdings 2 companies | 2 companies | — | Surgery |
| Various institutional and public market investors 2 companies | 2 companies | — | Neurological |
| Nitto Denko Corporation 2 companies | 2 companies | — | — |
| Cambrian Biopharma 2 companies | 2 companies | — | Regenerative Medicine |
| Goldman Sachs Asset Management 2 companies | 2 companies | — | Oncology |
| Sofina 2 companies | 2 companies | — | Oncology |
| Korea Investment Partners (KIP) 2 companies | 2 companies | — | Oncology |
| OneVentures 2 companies | 2 companies | — | Immunology |
| Venture capital investors (unspecified) 2 companies | 2 companies | — | Oncology |
| Blackbird Ventures 2 companies | 2 companies | — | Gastrointestinal |
| Apple Tree Partners 2 companies | 2 companies | — | Genetics & Genomics |
| Nexus Venture Partners 2 companies | 2 companies | — | Orthopedics |
| ICICI Prudential Asset Management 2 companies | 2 companies | — | Oncology |
| Life Sciences Fund 2 companies | 2 companies | — | Oncology |
| 8 Roads Ventures 2 companies | 2 companies | — | Oncology |
| UPMC Enterprises 2 companies | 2 companies | — | Neuroscience |
| MRL Ventures Fund 2 companies | 2 companies | — | Ophthalmology |
| Canaan 2 companies | 2 companies | — | Oncology |
| Advent International 2 companies | 2 companies | — | Vaccines |
| Chinese healthcare-focused venture capital firms 2 companies | 2 companies | — | Oncology |
| Undisclosed Private Investors 2 companies | 2 companies | — | Oncology |
| Agent Capital 2 companies | 2 companies | — | Cardiovascular |
| Maravai LifeSciences 2 companies | 2 companies | — | — |
| China Merchants Capital 2 companies | 2 companies | — | Oncology |
| a16z Bio + Health 2 companies | 2 companies | — | Oncology |
| IDG Ventures India 2 companies | 2 companies | — | Preventive Health |
| National Human Genome Research Institute (NHGRI) 2 companies | 2 companies | — | Oncology |
| Johnson & Johnson Innovation - JJDC 2 companies | 2 companies | — | Infectious Diseases |
| Local government guidance funds 2 companies | 2 companies | — | Oncology |
| Private venture capital 2 companies | 2 companies | — | Oncology |
| HOPU Investments 2 companies | 2 companies | — | Oncology |
| Information not publicly disclosed 2 companies | 2 companies | — | Oncology |
| Fidelity Investments 2 companies | 2 companies | — | Oncology |
| Venture capital firms (specific names not widely published) 2 companies | 2 companies | — | Oncology |
| Warburg Pincus 2 companies | 2 companies | — | Oncology |
| Jeff Bezos 2 companies | 2 companies | — | Age-related Diseases |
| Waterman Ventures 2 companies | 2 companies | — | Hematology |
| Menlo Ventures 2 companies | 2 companies | — | Rare Genetic Diseases |
| Enterprise Ireland 2 companies | 2 companies | — | Cardiopulmonary |
| HealthQuest Capital 2 companies | 2 companies | — | Oncology |
| venBio 2 companies | 2 companies | — | Rare Diseases |
| Alzheimer's Drug Discovery Foundation 2 companies | 2 companies | — | Neurology |
| Hatteras Venture Partners 2 companies | 2 companies | — | Cardiology |
| Sixth Street 2 companies | 2 companies | — | Oncology |
| National Institute of Mental Health (NIMH) 2 companies | 2 companies | — | Neurology |
| Genesis Biotechnology Group 2 companies | 2 companies | — | Oncology |
| Biocodex 2 companies | 2 companies | — | Addiction |
| European Union 2 companies | 2 companies | — | Addiction |
| Sambrinvest 2 companies | 2 companies | — | Autoimmune Diseases |
| Undisclosed Venture Investors 2 companies | 2 companies | — | Oncology |
| B Capital 2 companies | 2 companies | — | Oncology |
| 5Y Capital 2 companies | 2 companies | — | Oncology |
| Morningside Venture Capital 2 companies | 2 companies | — | Oncology |
| Goldstone Investment 2 companies | 2 companies | — | Oncology |
| Bpifrance Large Ventures 2 companies | 2 companies | — | Oncology |
| Accel 2 companies | 2 companies | — | Oncology |
| National Institutes of Health (NIH SBIR) 2 companies | 2 companies | — | Parkinson's Disease |
| Alpha Wave Global 2 companies | 2 companies | — | Immunology |
| Fonds de solidarité FTQ 2 companies | 2 companies | — | Ophthalmology |
| PureTech Health 2 companies | 2 companies | — | Neuroscience |
| Vinnova (Sweden's Innovation Agency) 2 companies | 2 companies | — | Infectious Disease |
| SFC Capital 2 companies | 2 companies | — | Ophthalmology |
| National Institutes of Health (Grant Provider) 2 companies | 2 companies | — | Oncology |
| Series C Investors (unspecified) 2 companies | 2 companies | — | Rare Genetic Diseases |
| 3B Future Health Fund 2 companies | 2 companies | — | Orthopedics |
| International Chemical Investors Group (ICIG) 2 companies | 2 companies | — | — |
| TPG Capital 2 companies | 2 companies | — | Cardiovascular |
| JDRF 2 companies | 2 companies | — | Type 1 Diabetes |
| CDTI (NEOTEC Grant) 2 companies | 2 companies | — | Neurodegenerative Diseases |
| Management 2 companies | 2 companies | — | Major Depressive Disorder |
| GT Healthcare Capital Partners 2 companies | 2 companies | — | Oncology |
| Fannin 2 companies | 2 companies | — | Oncology |
| Flinn Foundation 2 companies | 2 companies | — | Hydrocephalus |
| Lyzz Capital 2 companies | 2 companies | — | Oncology |
| Go Capital 2 companies | 2 companies | — | Infertility |
| U.S. Government SBIR Program 2 companies | 2 companies | — | Metabolic Disorders |
| Life Science Angels 2 companies | 2 companies | — | Infectious Disease |
| Sanderling Ventures 2 companies | 2 companies | — | Cardiovascular |
| Adjuvant Capital 2 companies | 2 companies | — | Infectious Disease |
| Solas BioVentures 2 companies | 2 companies | — | Cardiovascular |
| Paragon Biosciences 2 companies | 2 companies | — | Immune-mediated diseases |
| European Commission (Horizon 2020 Grant) 2 companies | 2 companies | — | Cardiovascular |
| Yuvaan Tiwari Foundation 2 companies | 2 companies | — | Oncology |
| Sutter Hill Ventures 2 companies | 2 companies | — | Oncology |
| Ascenta Capital 2 companies | 2 companies | — | Metabolic Diseases |
| Grifols 2 companies | 2 companies | — | Oncology |
| National Science Foundation (Grant) 2 companies | 2 companies | — | Maternal Health |
| Series B Investors (Unnamed) 2 companies | 2 companies | — | Cardiovascular Disease |
| Healthspan Capital 2 companies | 2 companies | — | Oncology |
| Age1 2 companies | 2 companies | — | Oncology |
| Felicis Ventures 2 companies | 2 companies | — | Oncology |
| Eurofins Scientific 2 companies | 2 companies | — | Organ Transplantation |
| National Institutes of Health (SBIR/STTR grants) 2 companies | 2 companies | — | Cardiovascular |
| National Science Foundation (SBIR grants) 2 companies | 2 companies | — | — |
| Kleiner Perkins 2 companies | 2 companies | — | Age-related Diseases |
| Dimension Capital 2 companies | 2 companies | — | Age-related Diseases |
| Bay City Capital 2 companies | 2 companies | — | Oncology |
| Strategic Investors (Undisclosed) 2 companies | 2 companies | — | Oncology |
| Michael J. Fox Foundation 2 companies | 2 companies | — | Neurodegenerative Diseases |
| NuFund Venture Group 2 companies | 2 companies | — | Dermatology |
| Cinven 2 companies | 2 companies | — | Various (Generics) |
| Bain Capital 2 companies | 2 companies | — | Various (Generics) |
| U.S. Venture Partners 2 companies | 2 companies | — | Cardiovascular |
| Treo Ventures 2 companies | 2 companies | — | Cardiovascular |
| Marcus Foundation 2 companies | 2 companies | — | Ophthalmology |
| OKG Capital 2 companies | 2 companies | — | Central Nervous System |
| Bill & Melinda Gates Foundation (Grant) 2 companies | 2 companies | — | Maternal Health |
| Militia Hill Ventures 2 companies | 2 companies | — | Rare Diseases |
| Series C Investors 2 companies | 2 companies | — | Musculoskeletal Diseases |
| Amplify Partners 2 companies | 2 companies | — | — |
| National Institute of Dental and Craniofacial Research (NIDCR) 2 companies | 2 companies | — | Oncology |
| Biovance Capital 2 companies | 2 companies | — | Oncology |
| Angelini Ventures 2 companies | 2 companies | — | Oncology |
| Eurazeo 2 companies | 2 companies | — | Oncology |
| Cancer Research Horizons 2 companies | 2 companies | — | Oncology |
| Good Growth Capital 2 companies | 2 companies | — | Oncology |
| AMETEK 2 companies | 2 companies | — | Ophthalmology |
| Google Ventures (GV) 2 companies | 2 companies | — | Diabetes |
| ArrowMark Partners 2 companies | 2 companies | — | Rare Genetic Neurodevelopmental Disorders |
| 4BIO Capital 2 companies | 2 companies | — | Oncology |
| TMC Venture Fund 2 companies | 2 companies | — | Oncology |
| Nipro Corporation (Parent Company) 2 companies | 2 companies | — | Renal Disease |
| National Institutes of Health (SBIR) 2 companies | 2 companies | — | Oncology |
| Runway Healthcare 2 companies | 2 companies | — | Cardiovascular |
| Elm Street Ventures 2 companies | 2 companies | — | Oncology |
| Pace Ventures 2 companies | 2 companies | — | Endometriosis |
| National Cancer Institute (SBIR Grants) 2 companies | 2 companies | — | Oncology |
| Revival Healthcare Capital 2 companies | 2 companies | — | Gastroenterology |
| aMoon Fund 2 companies | 2 companies | — | Oncology |
| Highlight Capital 2 companies | 2 companies | — | Neurodegenerative Diseases |
| NYBC Ventures 2 companies | 2 companies | — | Immunodeficiencies |
| Beiersdorf 2 companies | 2 companies | — | Parkinson's Disease |
| VentureWell 2 companies | 2 companies | — | Critical Care |
| Genesys Capital 2 companies | 2 companies | — | Urology |
| Osage University Partners 2 companies | 2 companies | — | Oncology |
| Lightchain Capital, LLC 2 companies | 2 companies | — | Oncology |
| Series A Investors (unnamed) 2 companies | 2 companies | — | Critical Care |
| NetScientific plc 2 companies | 2 companies | — | Oncology |
| Wellcome Trust 2 companies | 2 companies | — | Ophthalmology |
| AMED Ventures 2 companies | 2 companies | — | Cardiovascular Disease |
| Logos Capital 2 companies | 2 companies | — | Obesity |
| Innovation Fund Denmark 2 companies | 2 companies | — | Neurodegenerative Diseases |
| Sonder Capital 2 companies | 2 companies | — | Cardiovascular |
| Shionogi & Co., Ltd. 2 companies | 2 companies | — | HIV/AIDS |
| Korys 2 companies | 2 companies | — | Oncology |
| HCVC 2 companies | 2 companies | — | Oncology |
| Verve Ventures 2 companies | 2 companies | — | Oncology |
| Undisclosed Investors 2 companies | 2 companies | — | Oncology |
| Asahi Kasei 2 companies | 2 companies | — | Hematology |
| Asabys Partners 2 companies | 2 companies | — | Autoimmune Diseases |
| INNVIERTE (CDTI) 2 companies | 2 companies | — | Autoimmune Diseases |
| Supernova Invest 2 companies | 2 companies | — | Ophthalmology |
| Financière Arbevel 2 companies | 2 companies | — | Ophthalmology |
| SFPIM 2 companies | 2 companies | — | Inflammatory Bowel Diseases |
| atai Life Sciences 2 companies | 2 companies | — | Neuroscience |
| Dermapharm AG 2 companies | 2 companies | — | Allergy |
| Ajinomoto Co., Inc. 2 companies | 2 companies | — | Gastroenterology |
| Safar Partners 2 companies | 2 companies | — | Ophthalmology |
| AMR Action Fund 2 companies | 2 companies | — | Infectious Disease |
| BNP Paribas Développement 2 companies | 2 companies | — | Infectious Disease |
| Altaris Capital Partners 2 companies | 2 companies | — | — |
| European Regional Development Fund (EFRE) 2 companies | 2 companies | — | Oncology |
| Seed Round Investors (Undisclosed) 2 companies | 2 companies | — | Dermatology |
| H.I.G. Capital 2 companies | 2 companies | — | Spine Surgery |
| dievini Hopp BioTech holding 2 companies | 2 companies | — | Infectious Disease |
| Crowdcube Investors 2 companies | 2 companies | — | Immunology |
| Takeda Ventures 2 companies | 2 companies | — | Rare Diseases |
| Gamma Biosciences 2 companies | 2 companies | — | Oncology |
| ND Capital 2 companies | 2 companies | — | CNS |
| German Federal Ministry of Education and Research (BMBF) 2 companies | 2 companies | — | Autoimmune Diseases |
| Quan Capital 2 companies | 2 companies | — | Oncology |
| WiSEED 2 companies | 2 companies | — | Chronic Rhinitis |
| Abu Dhabi Investment Authority (ADIA) 2 companies | 2 companies | — | Neuroscience |
| Eshelman Ventures 2 companies | 2 companies | — | Urology |
| Schroders Capital 2 companies | 2 companies | — | Neuropsychiatry |
| Bioqube Ventures 2 companies | 2 companies | — | Oncology |
| Fund+ 2 companies | 2 companies | — | Infectious Diseases |
| GHO Capital 2 companies | 2 companies | — | Oncological |
| Avalon Ventures 2 companies | 2 companies | — | Orthopedics |
| Correlation Ventures 2 companies | 2 companies | — | Orthopedics |
| Patricia Industries (Investor AB) 2 companies | 2 companies | — | Infectious Disease |
| European Innovation Council (EIC) Accelerator 2 companies | 2 companies | — | Women's Health |
| Danish Growth Fund 2 companies | 2 companies | — | Neurology |
| ClavystBio 2 companies | 2 companies | — | Oncology |
| EDBI 2 companies | 2 companies | — | Oncology |
| Blackstone Life Sciences 2 companies | 2 companies | — | Oncology |
| EIT Health 2 companies | 2 companies | — | Reproductive Health |
| RiverVest Venture Partners 2 companies | 2 companies | — | Oncology |
| CDTI 2 companies | 2 companies | — | Neurology |
| CDTI Innvierte 2 companies | 2 companies | — | Neurology |
| Bernina BioInvest 2 companies | 2 companies | — | Obesity |
| Redalpine 2 companies | 2 companies | — | Obesity |
| British Business Bank 2 companies | 2 companies | — | Women's Health |
| ALS Association 2 companies | 2 companies | — | Amyotrophic Lateral Sclerosis (ALS) |
| Industrifonden 2 companies | 2 companies | — | Central Nervous System (CNS) Disorders |
| Creator Fund 2 companies | 2 companies | — | Central Nervous System (CNS) Disorders |
| Pureos Bioventures 2 companies | 2 companies | — | Autoimmune Diseases |
| Lichtsteiner Foundation 2 companies | 2 companies | — | Oncology |
| Vensana Capital 2 companies | 2 companies | — | Chronic Venous Insufficiency |
| Lantheus Holdings, Inc. 2 companies | 2 companies | — | Cardiology |
| FUJIFILM Holdings Corporation 2 companies | 2 companies | — | Oncology |
| Roche Group 2 companies | 2 companies | — | Oncology |
| The Foundry 2 companies | 2 companies | — | Cardiovascular |
| Eir Ventures 2 companies | 2 companies | — | Oncology |
| Eli Lilly and Company 2 companies | 2 companies | — | Oncology |
| Piper Sandler 2 companies | 2 companies | — | Oncology |
| Oxford Science Enterprises 2 companies | 2 companies | — | Neurodegenerative Diseases |
| Apollo Health Ventures 2 companies | 2 companies | — | Neurodegenerative Diseases |
| OrbiMed Advisors 2 companies | 2 companies | — | Respiratory |
| PPF Group 2 companies | 2 companies | — | Oncology |
| Vertex Ventures 2 companies | 2 companies | — | Oncology |
| HERAN Partners 2 companies | 2 companies | — | Oncology |
| European Union (Horizon 2020 Grant) 2 companies | 2 companies | — | Neurovascular |
| Creacion Ventures 2 companies | 2 companies | — | Cardiovascular |
| i&i Prague 2 companies | 2 companies | — | Oncology |
| Catalys Pacific 2 companies | 2 companies | — | Nephrology |
| Venture Capital Backers (unspecified) 2 companies | 2 companies | — | Neurology |
| Catalio Capital Management 2 companies | 2 companies | — | Neuropsychiatric Disorders |
| CDH Investments 2 companies | 2 companies | — | Ophthalmology |
| European Innovation Council (EIC) 2 companies | 2 companies | — | Neurology |
| British Patient Capital 2 companies | 2 companies | — | Chronic Pain |
| ANRI 2 companies | 2 companies | — | Oncology |
| NEDO (Grant) 2 companies | 2 companies | — | Oncology |
| Panacea Venture 2 companies | 2 companies | — | Oncology |
| Likely venture capital and private equity firms (specific names not publicly listed) 2 companies | 2 companies | — | Oncology |
| Japan Agency for Medical Research and Development (AMED) 2 companies | 2 companies | — | Neurology |
| GSR Ventures 2 companies | 2 companies | — | Digital Health |
| Data Collective 2 companies | 2 companies | — | Oncology |
| Sekisui Chemical Co., Ltd. 2 companies | 2 companies | — | Infectious Disease |
| China Merchants Bank International 2 companies | 2 companies | — | Regenerative Medicine |
| SMBC Venture Capital Co., Ltd. 2 companies | 2 companies | — | Oncology |
| BNDES 2 companies | 2 companies | — | Dermatology |
| Peregrine Ventures 2 companies | 2 companies | — | Cardiovascular |
| Sequoia Capital Israel 2 companies | 2 companies | — | Oncology |
| Byers Capital 2 companies | 2 companies | — | Oncology |
| TOHO HOLDINGS CO., LTD. 2 companies | 2 companies | — | Rare Diseases |
| Fidelity 2 companies | 2 companies | — | Oncology |
| Medi-Capital 2 companies | 2 companies | — | Spinal Disorders |
| A*STAR 2 companies | 2 companies | — | Oncology |